We are aware of current issues with the ONS login. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
-
Modafinil/Armodafinil - Cognitive Impairment
-
Methylphenidate - Cognitive Impairment
-
Exercise - Cognitive Impairment
-
Cognitive Behavioral Interventions/Approach - Cognitive Impairment
-
Olanzapine - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
Triple Drug Regimen - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
Benzodiazepines for Anticipatory Chemotherapy-Induced Nausea and Vomiting - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
5HT3 and Dexamethasone in Pediatric Patients - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
Serotonin 5HT3 Receptor Antagonists (5HT3) - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
Neurokinin-1 Receptor Antagonist (NK1) - Chemotherapy-Induced Nausea and Vomiting—Pediatric
Subscribe to